NovaMatrix® manufacture PRONOVA® sodium alginate in our facilities in Norway. We operate according to GMP guidelines and ISO standards; ISO 9001:2015 and ISO 13485:2016.
Our Sodium Hyaluronate ultrapure products are produced by our partner, Kikkoman Biochemifa Company, Japan, under GMP guidelines; the Pharmaceutical Affairs Law of Japan, ICH Q7 and ISO standards; ISO 9001:2015 and ISO 14001:2004.